Republicans have faced pushback for their plans to pay for Trump’s tax cuts by reducing federal Medicaid funding and by ...

A new agreement between the FDA and Avidity Biosciences could further assuage industry concerns about the agency’s stance on ...

The Trump administration’s gutting of global aid is threatening to collapse a network of laboratories responsible for global ...

Budget documents released Friday provide the first clear indication of the priorities of the proposed Administration for a ...

Several hundred NIH employees signed on to a letter rebuking agency actions since the start of President Trump's second term ...

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

Metsera, the obesity-focused biotech, said this morning that its drug candidate targeting the amylin hormone showed marked ...

Fears about the FDA mposing steep barriers to gene therapies for rare diseases appeared moot at an agency roundtable ...

Companies like Sweetgreen, Daily Harvest, and Thrive Market have strong ties to MAHA leaders, including Casey and Calley ...

Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial, the company said ...

The Trump executive order is not a pathway to a “gold standard” — it is a blueprint for politicizing science and ...

Four members of the ACIP, which advises the CDC on vaccination policy, have had their status as special government employees ...